Sagicor Life Inc. Sep 11

  • ID: 1927512
  • September 2011
  • Standard & Poors
1 of 3

Dominant market position in the Caribbean region; Increasing geographic diversification; and Strong capitalization. Volatility on profits due to catastrophic exposures; and High, albeit decreasing, concentration in Jamaica. Standard & Poor's Ratings Services' counterparty credit and financial strength ratings reflect Sagicor Life Inc.'s (Sagicor) dominant market position as the leading life insurer in the Caribbean, increasing geographic diversification, and strong capitalization. These positive factors are partially offset by a relatively high, though decreasing, concentration of revenues (28%) in Jamaica in 2010; volatility on profitability ratios arising from the company's exposure to catastrophic risks arising from its property and casualty (P/C) business; and the challenging economic conditions in most of the economies where Sagicor does business. Sagicor has leading positions in the...

Companies mentioned in this report are: Sagicor Life Inc.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Sagicor Life Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.